SCHEMBL6644541

SCHEMBL6644541

Cc1ccc(-c2ccccc2C(=O)Nc2ccc(N(CCn3nccc3NC(c3ccccc3)(c3ccccc3)c3ccccc3)C(=O)O)nc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 4/20 0.37
L3MBTL1 Q9Y468 1/20 0.35
AGTR1 P30556 2/20 0.35
AGTR2 P50052 1/20 0.35
ALDH1A1 P00352 1/20 0.35
KMT2A Q03164 1/20 0.35
AVPR2 P30518 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
LMNA P02545 1/20 0.34
KDM4E B2RXH2 1/20 0.34
AURKA O14965 1/20 0.33
LTB4R2 Q9NPC1 1/20 0.33
POLB P06746 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
CHRNB2 P17787 1/20 0.33
CHRNB4 P30926 1/20 0.33
CHRNA3 P32297 1/20 0.33
CHRNA4 P43681 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6645963 0.89 ALDH1A1 (0.39) L3MBTL1AGTR1AGTR2ALDH1A1KMT2A
SCHEMBL6646519 0.76 GAA (0.41) L3MBTL1ALDH1A1NPC1RAB9ALMNA
SCHEMBL6645405 0.70 HCRTR2 (0.36) NPC1RAB9ALMNA
SCHEMBL6648250 0.70 L3MBTL1 (0.43) L3MBTL1ALDH1A1KMT2ANPC1RAB9A
SCHEMBL6647719 0.69 F2 (0.31)
SCHEMBL6648246 0.69 ALDH1A1 (0.44) L3MBTL1AGTR1AGTR2ALDH1A1KMT2A
SCHEMBL6643979 0.69 HCRTR2 (0.41) L3MBTL1ALDH1A1KMT2AAVPR2NPC1
SCHEMBL6645107 0.68 KCNA5 (0.39) ALDH1A1KMT2ANPC1RAB9ALMNA
SCHEMBL6645258 0.68 ALDH1A1 (0.36) ALDH1A1KMT2ANPC1RAB9AKDM4E
SCHEMBL6646621 0.67 PKM (0.38) L3MBTL1ALDH1A1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040133008-A1 Amide compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040133008-A1 Amide compounds APOB, APOL1, LDLR DGAT1 487/4885L3MBTL1 1609/4885AGTR1 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.